2007
DOI: 10.1016/j.ejso.2007.07.167
|View full text |Cite
|
Sign up to set email alerts
|

Peri-operative FOLFOX4 chemotherapy and surgery for resectable liver metastases from colorectal cancer (CRLM): Final efficacy results of the EPOC Intergroup randomized phase III study (EORTC 40983)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2008
2008
2010
2010

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…The role of neo-adjuvantchemotherapyinthe treatment of multiple colorectal metastases,ormetastaseswith potentially threatened resectionmargins has been demonstratedinretrospective studies. [16][17][18][19] However,i ts role in patients with resectable disease has not yet been established. Chemotherapy is commonly used in conjunction withs urgery to down-size tumours previously judged inoperable.…”
Section: Earlya Nd Long-term Outcomes Of Liver Resection and Diaphragmentioning
confidence: 99%
See 1 more Smart Citation
“…The role of neo-adjuvantchemotherapyinthe treatment of multiple colorectal metastases,ormetastaseswith potentially threatened resectionmargins has been demonstratedinretrospective studies. [16][17][18][19] However,i ts role in patients with resectable disease has not yet been established. Chemotherapy is commonly used in conjunction withs urgery to down-size tumours previously judged inoperable.…”
Section: Earlya Nd Long-term Outcomes Of Liver Resection and Diaphragmentioning
confidence: 99%
“…[2][3][4]16 The French association series, and more recent data from the EPOC phase III trials, have suggestedt hat survival after liver resection can be improvedinpatients treatedwith neo-adjuvant chemotherapy followedbyliverresection. 16,18,20 Of patients who had simultaneous liverr esection and diaphragm excision,8 5.2%d id not have tumour involved in the diaphragm. It may be, therefore, that the significantly poorer outcome is due, in part, to aless favourable biology in addition to advanced stage of disease.…”
Section: Earlya Nd Long-term Outcomes Of Liver Resection and Diaphragmentioning
confidence: 99%
“…The role of neo-adjuvantchemotherapyinthe treatment of multiple colorectal metastases,ormetastaseswith potentially threatened resectionmargins has been demonstratedinretrospective studies. [16][17][18][19] However,i ts role in patients with resectable disease has not yet been established. Chemotherapy is commonly used in conjunction withs urgery to down-size tumours previously judged inoperable.…”
Section: Overall Survival (%)mentioning
confidence: 99%
“…However, studies have shown the benefit of neo-adjuvant chemotherapy in rendering unresectable tumours into operable candidates 11,16,17 , and more recently, early data from randomised trials have suggested that a standard policy of neo-adjuvant chemotherapy followed by liver resection may positively affect progression free survival 18,19 .…”
Section: Introductionmentioning
confidence: 99%